TNYA- Tenaya Therapeutics, Inc.

Name: Tenaya Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Tenaya Therapeutics, Inc. (TNYA) has 11 insiders with recent SEC Form 4 filings, including 11 buys and 1 sell. TNYA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Ali Faraz	952.3K	$915.1K	-
Other	Tingley Whittemore	318.5K	$306.1K	-
VP	Higa Tomohiro	175.5K	$168.7K	-
Dir	Srivastava Deepak	107.4K	$103.2K	-
Dir	Parschauer Karah Herdman	107.4K	$103.2K	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 16, 2023	Ali Faraz66	Chief Executive Officer	Sell	5,563	$3.81	$21,195.03	-4.5%	-49.7%	-21.9%
Mar 10, 2023	Goeddel David V71	Director, 10% Owner	Buy	6,779	$2.60	$17,595.57	-	+183.5%	+145.2%
Mar 10, 2023	Column Group III Gp, LP77	10% Owner	Buy	6,779	$2.60	$17,595.57	-	+183.5%	+145.2%
Feb 8, 2023	Goeddel David V71	Director, 10% Owner	Buy	1,500,000	$2.60	$3,900,000.00	+15.2%	+136.6%	+85.9%
Feb 8, 2023	Column Group III Gp, LP77	10% Owner	Buy	1,500,000	$2.60	$3,900,000.00	+15.2%	+136.6%	+85.9%
Jan 19, 2023	Column Group III Gp, LP77	10% Owner	Buy	69,739	$2.50	$174,201.05	+0.7%	+40.6%	+50.2%
Jan 19, 2023	Goeddel David V71	Director, 10% Owner	Buy	69,739	$2.50	$174,201.05	+0.7%	+40.6%	+50.2%
Jan 18, 2023	Column Group III Gp, LP77	10% Owner	Buy	185,151	$2.51	$464,827.06	+1.0%	+21.4%	+26.6%
Jan 18, 2023	Goeddel David V71	Director, 10% Owner	Buy	185,151	$2.51	$464,827.06	+1.0%	+21.4%	+26.6%
Nov 21, 2022	Srivastava Deepak	Director	Buy	230,769	$2.60	$599,999.40	+162.9%	+36.9%	-22.3%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC